
|Videos|April 14, 2016
What Are The Barriers to HCV Treatment?
Author(s)Contagion Editorial Staff
Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.
Advertisement
Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Patient With Novel Strain of Avian Influenza Dies
2
Cefiderocol Shows Activity Against Difficult-to-Treat Pathogens
3
Impact of Nonmedical Exemption Repeal on US Kindergarten Immunization Rates
4
DoxyPEP Use Linked to Increased High-Level Tetracycline Resistance in Neisseria gonorrhoeae
5




























































































































































































































































































